Content deleted Content added
m clean up |
|||
Line 39:
TB Alliance has the largest pipeline of TB drugs in history<ref name=":0" /> and part of TB Alliance’s stated mission is to ensure that any new treatments are affordable and accessible in the [[developing world]], and that they are adopted as soon as they become available.<ref>{{Cite web|url=https://www.tballiance.org/about/mission|title=About TB Alliance|website=TB Alliance|language=en|access-date=2019-04-25}}</ref> Pricing terms are included in all licensing contracts and end products are designed to be easy for patients to take. TB Alliance also collaborates with national and international partners, working to ensure that new therapies are adopted and accessible to [[healthcare provider]]s and patients via local channels.
In February 2019, TB Alliance’s application for the novel tuberculosis (TB) medicine [[pretomanid]] was accepted for review by the U.S. FDA.<ref name=":1">{{Cite web|url=https://www.tballiance.org/news/pretomanid-enters-FDA-review|title=TB Medicine Pretomanid Enters Regulatory Review Process in the United States {{!}} TB Alliance|website=www.tballiance.org|access-date=2019-04-25}}</ref> In August 2019, TB Alliance's tuberculosis (TB) medicine
==Treating Drug-Resistant TB==
| |||